XML 41 R29.htm IDEA: XBRL DOCUMENT v3.24.3
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Schedule of option activity
          
       Weighted 
   Number of   Average 
   Options   Exercise 
   Outstanding   Price 
Outstanding at December 31, 2023   481,858   $10.41 
Granted   292,000    5.58 
Forfeited   (70,200)   13.19 
Outstanding at September 30, 2024   703,658   $7.19 
Schedule of assumptions for options granted
       
   Nine months ended
September 30, 2024
 

Nine months ended

September 30, 2023

Expected volatility  89.04% - 90.37%   90.2% - 94.5%
Expected term  6.5 - 7 Years   6.5 - 7 Years
Risk-free interest rate  3.67% - 4.25%   3.55% - 4.47%
Weighted-average FV  $4.45   $9.71
Schedule of restricted stock awards
          
    

Nonvested

Shares

    

Weighted-

Average Grant-

Date Fair Value

 
Nonvested at December 31, 2023   1,238   $20.17 
Granted   80,645    6.20 
Vested   (56,374)   6.43 
Forfeited   (10,081)   6.21 
Nonvested at September 30, 2024   14,808   $6.48 
Schedule of activity of warrants outstanding
          
  

Number of

Warrants

   Weighted Average Exercise Price 
Exercisable at December 31, 2023   610,745   $9.80 
Granted        
Expired   (282,334)    
Exercised   (128,411)   6.30 
Outstanding at September 30, 2024   200,000   $17.00 
Exercisable at September 30, 2024   200,000   $17.00